Nasdaq IPOs

Compass Therapeutics, a Phase 1 biotech developing novel antibody therapies for solid tumors, withdrew its plans for an initial public offering on Friday. It had filed to raise $50 million by offering 9 million shares at a price range of $5 to $6. The Cambridge, MA-based company

Sigilon Therapeutics, a clinical stage biotech developing molecular therapeutics for chronic diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company is pioneering a new class of therapeutics for patients with chronic diseases

Inhibikase Therapeutics, an early stage biotech developing kinase inhibitors for Parkinson's and related disorders, postponed its IPO on Friday. It had planned to raise $15 million by offering 1.4 million shares at a price range of $10 to $12. The Atlanta, GA-based company was f

Yatsen Holding, which makes cosmetics under the Perfect Diary, Little Ondine, and Abby's Choice brands in China, announced terms for its IPO on Friday. The Guangzhou, China-based company plans to raise $558 million by offering 58.8 million ADSs at a price range of $8.50 to $10.5

CF Finance Acquisition III, the third blank check company formed by Cantor Fitzgerald, raised $200 million by offering 20 million units at $10. ?Each unit consists of one share of common stock and one-third of a warrant, exercisable $11.50. The company is led by CEO and Cha

Pine Island Acquisition, a blank check company formed by Pine Island Capital Partners targeting the defense industry, lowered the proposed deal size for its upcoming IPO on Friday. The Fort Lauderdale, FL-based company now plans to raise $250 million by offering 25 million units

DoorDash, an online restaurant delivery service in 3,000 cities, filed on Friday with the SEC to raise up to $100 million in an initial public offering. However, this is likely a placeholder for a deal we estimate could raise up to $2 billion. The company's filing tees it up

IN8bio, a Phase 1 oncology biotech developing allogeneic gamma-delta T cell therapies, postponed its IPO on Friday. It had filed to raise $75 million by offering 4.7 million shares at a price range of $15 to $17. The New York, NY-based company was founded in 2016 and had planned

Maravai LifeSciences, which provides acid production, safety testing, and protein detection products for biotechs, announced terms for its IPO on Friday. The San Diego, CA-based company plans to raise $1.3 billion by offering 50 million shares at a price range of $24 to $27. At

INSU Acquisition III, the third blank check company formed by Cohen & Company targeting the insurance industry, filed on Friday with the SEC to raise up to $200 million in an initial public offering. The Philadelphia, PA-based company plans to raise $200 million by offering

Better World Acquisition, a blank check company formed by N*GEN Partners targeting a healthy living business with a strong ESG profile, raised $110 million by offering 11 million units at $10. The company offered 1 million more units than anticipated. It originally planned to off

dMY Technology Group III, the third blank check company formed by Niccolo de Masi and Harry You targeting an app business, raised $275 million by offering 27.5 million units at $10. The company offered 2.5 million more units than anticipated. Each unit consists of one share of co

Health Assurance Acquisition, a blank check company formed by General Catalyst targeting healthcare technology, raised $500 million by offering 50 million SAIL (Stakeholder Aligned Initial Listing) securities at $10. Each SAIL security consists of one share of common stock and on

Rodgers Silicon Valley Acquisition, a blank check company targeting a technology business in Silicon Valley, filed on Thursday with the SEC to raise up to $200 million in an initial public offering. The Woodside, CA-based company plans to raise $200 million by offering 20 millio

Seer, which provides a proteograph product suite for biomedical research, filed on Thursday with the SEC to raise up to $150 million in an initial public offering. The company aims to commercialize proteome research products starting with its initial product, the Proteograph Pro

Hydrofarm Holdings Group, a hydroponics and specialty indoor gardening market supplier, filed on Thursday with the SEC to raise up to $100 million in an initial public offering. Hydrofarm is a leading independent distributor and manufacturer of controlled environment agriculture

NeoGames, which provides online gaming technology and services to lottery operators, announced terms for its IPO on Thursday. The Tel Aviv, Israel-based company plans to raise $72 million by offering 4.8 million shares (45% insider) at a price range of $14 to $16. At the midpoin

NeoGames, which provides online gaming technology and services to lottery operators, announced terms for its IPO on Thursday. The Luxembourg-based company plans to raise $72 million by offering 4.8 million shares (45% insider) at a price range of $14 to $16. At the midpoint of t

Sotera Health, which provides lab services to the medical device and pharma industries, announced terms for its IPO on Thursday. The Broadview Heights, OH-based company plans to raise $1.0 billion by offering 46.6 million shares at a price range of $20 to $23. At the midpoint of

Consonance-HFW Acquisition, a blank check company formed by Consonance Capital targeting the life science industry, lowered the proposed deal size for its upcoming IPO on Thursday. The Princeton, NJ-based company now plans to raise $80 million by offering 8 million units at $10.